甲型肝炎病毒總抗體檢測試劑的比較及初步應用
[Abstract]:Hepatitis A (hepatitis A) is divided into B infectious disease in China, which is caused by hepatitis A virus (Hepatitis A Virus, HAV). It is easy to cause the outbreak and epidemic of.HAV (Antibody to HAV, Anti-HAV) as an important index in epidemiological investigation. The positive indicates that there is HA. V infection history or immunization history is to strengthen the quality control of Anti-HAV total antibody test in laboratory, increase the credibility of the research results, and provide reference for the selection of sero epidemiological detection reagents for hepatitis A (hepatitis A). This study evaluates and compares the Anti-HAV total anti physical test agents sold in the market and in sero epidemiology. Preliminary application.
A quantitative method for the Anti-HAV total antibody was established by combining the optimal standard curve. The double ratio of the standard Anti-HAV antibody was diluted, and the reagent kit HAVAb2.0 was detected five times by the microparticle enzyme immunoassay method produced by American Abbott (Abbott) company. The Anti-HAV total antibody concentration X of the standard product was independent variable to determine the value CO/S. For the dependent variable, two kinds of conversion methods used in common logarithmic conversion and natural logarithm conversion, combined linear model, exponential model, and logistic model three fitting models to fit the standard curve, get six regression equations, all of which have statistical significance (F test, P0.001), of which the logistic regression model of two transformation modes is the highest R2, 0.9893. The mean value of the mean value of each concentration standard sample into two logistic regression equations is the least. In the three standard curve fitting models, the fitting effect of logistic regression is the best. No effect of the natural logarithms and the two common logarithm data transformation methods on the results of the fitting results is not observed.
In this study, the reference system of Anti-HAV and total antibody was established as a common platform for comparison of different reagents. In the case of 314 serum preparatory reference materials, under the condition that the quality control was qualified by "instant method", the HAVAb2.0 reagent of Abbott company was used to determine its Yin and Yang, and the preparatory reference of the test reagent grey area was obtained. Repeat the test three times, remove the preparatory reference material with inconsistent qualitative results, then adjust the internal composition of the reference system according to the quantitative results of the 311 prepared ginseng, and remove a part of the high concentration of the high concentration of the reference, and then increase the number of the weakly positive reference by the dilution reference. In the final system, there were 71 positive reference materials, including 12 10OOOmIU/ml, 11, 100 to 1000mIU/ml, 11, 64, 100 to 500mIU/ml, 17, 18 and 7 negative.
The evaluation and comparison of two kinds of enzyme immunoassay reagents for the detection of Anti-HAV total antibody were compared. The reference system established in this study was detected by A and B two, the CO/S value was recorded and the LN (CO/S+0.1) conversion was recorded, and the test samples were estimated by the generalized linearization estimation equation (Generalized Estimating Equation, GEE) model. The positive probability of the two reagents, the reliability index of the two reagents and the authenticity index, the intra group correlation coefficient (Intraclass Correlation Coefficient, ICC) and the coefficient of variation (Coefficient of Variability.CV) were 0.9971 and 5.7840% respectively, the B reagents were 0.9952 and 6.2931% (Bootstrap.P0.05), and all the A agents were tested. The area under the Receive Operation Characteristic (ROC) curve (Area Under Curve, AUC) and some (Partial) ROC curves (the specificity of 0.9 to 1) are 0.9557 and 0.0717 respectively, respectively, and B are 0.9404 and 0.0663, and the sensitivity under the fixed special degree of 0.005 in the interval 0.005 is 0.920 to 0.970. Degree, the sensitivity of A reagent B reagent (Bootstrap method, P0.05) when the specificity is 0.945,0.950,0.955,0.960, but when the specificity is other observation point, the difference of sensitivity is not statistically significant (Bootstrap, P0.05). CO/S value is converted to two classification qualitative data, and the coarse coincidence rate of A reagents (Crude Accuracy, CA) is obtained. Kappa values were 92.66% and 0.85, B reagents 90.40% and 0.80, A, B two reagents were 94.34% and 88.68% respectively, the specificity was 90.14% and 92.96%, the Youden index was 0.84 and 0.81. (Z test, P0.05). It can be seen that A, B two reagents all showed good diagnostic ability, although some index Statistics There are differences in learning, but whether the difference has practical significance is worth further exploring. In practical application, it can be selected according to specific circumstances.
On the basis of the comparison of the Anti-HAV total antibody test reagents, we conducted a preliminary serological survey on 587 Mongolian and Han Middle School Students in Bayannaoer, Inner Mongolia, and obtained a total positive rate of 14.31%. The factors of age, sex and nationality were analyzed by logistic regression, and the total resistance of Anti-HAV in different ages was obtained. It is suggested that the inoculation of hepatitis A vaccine should be strengthened among adolescents in this area to increase the positive rate of anti-HAV and prevent the outbreak or epidemic of hepatitis A.
【學位授予單位】:中國疾病預防控制中心
【學位級別】:碩士
【學位授予年份】:2013
【分類號】:R512.61
【參考文獻】
相關期刊論文 前10條
1 成軍,袁興旺,金晶,王國政,孫長貴,孫關忠;美國Abbott Axsym免疫分析儀性能初步評價[J];國外醫(yī)學.臨床生物化學與檢驗學分冊;2003年02期
2 容瑩;孫秀雙;鄭望春;詹卓玲;曾昭鑒;;乙型肝炎表面抗原檢測結果分析及灰區(qū)設置探討[J];檢驗醫(yī)學與臨床;2010年15期
3 李金明;;感染性疾病免疫測定的室內質量控制[J];醫(yī)學檢驗與臨床;2007年01期
4 胡孟冬;孫碧芳;周艷琴;邱志芳;;甲型肝炎減毒活疫苗的研究——毒株減毒與狨猴實驗[J];上海醫(yī)學;1988年11期
5 向金華,曹逸云,鐘光六,周德久,董德祥;甲型肝炎病毒呂8株的快速適應性培養(yǎng)[J];中國生物制品學雜志;1997年01期
6 張勇,趙守軍,歐陽培英;應用非線性方程計算甲肝總抗體滴度[J];中國生物制品學雜志;1998年04期
7 李成明,陳江婷,萬宗舉,崔俊生,練幼輝,尹紅章,趙偉,黃小芩,王祥,陳統(tǒng)球,尹衛(wèi)東;甲型肝炎滅活疫苗免疫原性的猴體實驗[J];中國生物制品學雜志;1999年04期
8 伍偉健;郭如華;;ELISA試驗灰區(qū)設置方法的探討[J];中國生物制品學雜志;2008年10期
9 Elisabetta Franco;Cristina Meleleo;Laura Serino;Debora Sorbara;Laura Zaratti;;Hepatitis A:Epidemiology and prevention in developing countries[J];World Journal of Hepatology;2012年03期
10 夏彥,潘曉平,劉元元,陳衛(wèi)中;廣義估計方程在臨床試驗重復測量資料中的應用[J];現代預防醫(yī)學;2005年05期
,本文編號:2167152
本文鏈接:http://sikaile.net/yixuelunwen/chuanranbingxuelunwen/2167152.html